Actemra 200 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB26FZQ80
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,655
Award facts
- Contract value 100% obligated
- $2,654.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,654.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Actemra 200 mg/10 mL vials. The contract, which is firm fixed-price with no set-aside designation, was awarded on October 24, 2025, with an ultimate completion date of November 17, 2025. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across the Department of Defense healthcare system.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively in government procurement. The company's PPV-G GEN V contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This authorization enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceuticals, biologics, and medical consumables to support military healthcare facilities worldwide, with the current award representing one of numerous delivery orders DMS Pharmaceutical Group has received since October 2025.
Quick answers
Who was awarded contract SPE2DB26FZQ80?
SPE2DB26FZQ80 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FZQ80 worth?
The government has obligated $2,655 on SPE2DB26FZQ80.
Is contract SPE2DB26FZQ80 an order under another contract?
Yes. SPE2DB26FZQ80 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB26FZQ80 competed?
The extent of competition for SPE2DB26FZQ80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award